Please login to the form below

Not currently logged in
Email:
Password:

Bayer appoints senior vice president for consumer health unit

Brenda Raphael joins from Pfizer, where she was general manager

Brenda RaphaelBayer has appointed Brenda Raphael as its new senior vice president and general manager of its therapeutic business unit of consumer health operations in North America.

She has previously served Pfizer as its general manager for US brands and her expertise lies in delivering financial gains to businesses and drive insight-led multi channel marketing to consumers.

Prior to this, she has held senior positions at the Coca-Cola Company and Procter & Gamble.

Natalie Bartner, president of North America consumer health division, Bayer, said: “Brenda has more than 20 years of experience in leading successful billion-dollar, consumer-focused brands.

“Her strengths in understanding customers, marketing and innovation will lead the therapeutics business unit to continue developing self-care solutions that help people live healthier lives.”

Raphael will report to Natalie Bartner and she will be based in New Jersey, US.

30th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics